Skip to content

Evaluation of Intestinal Microbiota Implication in Ruptured Intracranial Aneurysm

Evaluation of Intestinal Microbiota Implication in Ruptured Intracranial Aneurysm: a Comparison of Ruptured and Unruptured Patient With Taxonomic and Metabolic Evaluation of Microbiota

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05914636
Acronym
AneBiote
Enrollment
50
Registered
2023-06-22
Start date
2024-08-31
Completion date
2026-08-31
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Sacciform Aneurysm

Keywords

Intracranial aneurysm, intestinal microbiota, risk factor, ruptured

Brief summary

The physiopathology of intracranial aneurysm from initiation to ruptured is incompletely understood but included inflammation. The microbiota is known to interact with brain and can promote inflammation. The objective of this study is to describe microbiota with taxonomic and metabolomic analysis. A comparison between ruptured and unruptured intracranial aneurysm will be performed. The study hypothesis is that microbiota is different between ruptured and unruptured patient.

Interventions

BIOLOGICALanalysis of foecal microbiota

An analysis of foecal microbiota including taxonomic and metabolomic analysis will be performed and compared between ruptured and unruptured patient. confundens factors as diet, obesity for microbiota and as smoking, hypertension, size for aneurysm ruptured will be sampled and independence will be analyzed.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* one or more intracranial sacciform aneurysm ruptured or not in function of the inclusion group

Exclusion criteria

* Transient modification of microbiota: Antibiotherapy in the last 3 months, pre or probiotic in the last month, gastrostomy, ileostomy, bariatric surgery, digestive tract resection, gastro-duodenal ulcer surgery or during the last month, chronic inflammatory disease of the digestive tract (like Crohn), BMI for more than 30, Very restrictive diet (like vegan * Specific pathologies increasing the incidence of aneurysm ( kidney autosomic dominant polycystosis, Type 1 neurofibromatosis, Rendu-Osler, MArfan * Participation to a study with the objective of microbiota modification

Design outcomes

Primary

MeasureTime frameDescription
Taxonomic faecal microbiota descriptionThe faecal samples will be taken at 3 days+/-2 after the ruptured and during the arteriography for the unruptured group within 3 months after inclusionThe results of the taxonomic analysis of fecal samples will be described in the two groups. Interesting parameter will be selected for further analysis

Contacts

Primary ContactDumot Chloé, Dr PhD
chloe.dumot@chu-lyon.fr+334 72355839

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026